-
Ozone Drives Macrophage Efferocytosis to Mitigate Neuropathi
2026-07-22
This study demonstrates that ozone therapy alleviates neuropathic pain by enhancing macrophage efferocytosis through AMPK/Gas6-MerTK/SOCS3 pathway activation. The findings illuminate new mechanistic targets for neuroinflammation resolution and pain intervention.
-
SAG Mitigates Mitochondrial Dysfunction in Frataxin-Deficien
2026-07-22
Vicente-Acosta et al. demonstrated that pharmacological activation of the Hedgehog pathway via the Smoothened receptor agonist SAG prevents mitochondrial dysfunction and neurotoxicity in frataxin-deficient astrocytes, a key cellular model of Friedreich’s ataxia. These findings position SAG as a valuable tool for dissecting glial contributions to neurodegeneration and inform therapeutic strategies targeting neuron–glia interactions.
-
Grazoprevir/Elbasvir: Transforming HCV Genotype 1 and 4 Ther
2026-07-21
The reference review demonstrates that coformulated grazoprevir (MK-5172 hydrate) and elbasvir deliver highly effective, well-tolerated, and simplified regimens for hepatitis C virus (HCV) genotypes 1 and 4. These findings reshape standards for complex patient subgroups, including those with HIV/HCV coinfection or renal impairment, by achieving high sustained virologic response rates and reducing treatment burdens.
-
Methylprednisolone in Osteonecrosis Models: Protocols & Pitf
2026-07-21
Methylprednisolone, a synthetic glucocorticoid receptor agonist, enables precise modeling of inflammation-driven bone loss. This guide delivers actionable protocols, troubleshooting insights, and translational strategies for leveraging APExBIO’s Methylprednisolone in advanced osteonecrosis and anti-inflammatory research.
-
BMAL1 Phase Separation Drives Circadian Transcriptional Hubs
2026-07-20
A recent study reveals that BMAL1, a core circadian clock protein, regulates rhythmic gene expression by forming phase-separated nuclear condensates. This mechanism links the phosphorylation state of BMAL1's intrinsically disordered region (IDR) to the assembly of transcriptional hubs, advancing our understanding of temporal gene regulation and offering new strategies for functional phosphorylation site validation.
-
Cdk5 Inhibition Reverses Neuronal Ferroptosis via AMPK in St
2026-07-20
This study uncovers that downregulating Cdk5 mitigates hippocampal neuron ferroptosis after ischemic stroke by modulating the AMPK pathway and suppressing pro-inflammatory microglial polarization. These findings highlight the therapeutic potential of targeting Cdk5 and AMPK to reduce neuroinflammation and iron-dependent cell death in stroke.
-
Catalpol’s Multifaceted Anticancer Mechanisms: Review Insigh
2026-07-19
This comprehensive review synthesizes preclinical evidence on catalpol, an iridoid glycoside, highlighting its anticancer activity across diverse tumor types. The article details catalpol’s molecular mechanisms, including modulation of apoptosis, metastasis, inflammation, and synergy with chemotherapeutics, offering a foundation for translational research and future experimental design.
-
Sodium Salicylate: NF-κB Inhibitor Workflows in Tumor Resear
2026-07-18
Sodium salicylate delivers robust NF-κB pathway inhibition, enabling high-reproducibility workflows for inflammation and tumor stroma research. This guide details data-driven protocol parameters, troubleshooting tips, and practical insights from recent advances in pancreatic cancer models.
-
Solving Lab Assay Challenges with AP20187 (SKU B1274)
2026-07-17
This authoritative guide demonstrates how AP20187 (SKU B1274), a synthetic chemical inducer of dimerization, addresses core challenges in cell viability, proliferation, and cytotoxicity assays. Using real-world laboratory scenarios, we highlight its reproducibility, compatibility, and reliability for conditional gene expression and regulated cell therapy workflows.
-
Cy3-UTP in Live-Cell RNA Trafficking: Illuminating Endosomal
2026-07-17
Discover how Cy3-UTP, a Cy3-modified uridine triphosphate, enables unprecedented visualization of live-cell RNA trafficking and endosomal escape mechanisms. This article explores advanced fluorescence applications, protocol insights, and practical implications for RNA biology.
-
AICAR and the TRPV1-AMPK Axis: Precision Tools for Fibrosis
2026-07-16
Explore how AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) enables advanced metabolic disease and fibrosis research by targeting the TRPV1-AMPK pathway. This article reveals unique experimental strategies and protocol guidance for energy metabolism regulation and inflammation inhibition.
-
Pitavastatin (NK-104): Technical Guide for In Vitro Choleste
2026-07-16
Pitavastatin (NK-104) is a high-purity, HMG-CoA reductase inhibitor designed for precise in vitro inhibition of cholesterol biosynthesis in cellular and biochemical assays. It is best suited for cardiovascular and atherosclerosis research, particularly where mitophagy activation or CAMK1-PINK1 pathway modulation are of interest. This product is not validated for direct use in clinical or in vivo animal studies.
-
Enhancing Cell Assays with PKM2 Inhibitor (Compound 3k): SKU
2026-07-15
This article delivers scenario-driven guidance for integrating PKM2 inhibitor (compound 3k) (SKU B8217) into cell viability, proliferation, and immunometabolism assays. Drawing on peer-reviewed evidence and APExBIO’s product dossier, it addresses real laboratory challenges, from assay reproducibility to selective PKM2 targeting, to help biomedical researchers achieve robust, interpretable results in cancer and inflammation research.
-
BCKDK and STUB1 Modulate BCAT1 Stability in GBM Progression
2026-07-15
This study reveals how BCKDK-mediated phosphorylation and STUB1-dependent ubiquitination regulate BCAT1 activity and stability in glioblastoma (GBM). The findings uncover a post-translational modification axis that promotes GBM growth, suggesting new molecular targets for therapeutic intervention and translational process study.
-
GANT61 as a GLI Inhibitor: Protocols, Troubleshooting, and C
2026-07-14
GANT61 unlocks precise GLI1/2 inhibition, empowering researchers to dissect Hedgehog pathway biology and unravel mechanisms of tumor immune evasion. This article provides actionable protocols, troubleshooting guidance, and connects landmark studies to practical laboratory workflows for cancer research.